Search

Search Constraints

You searched for: Author/Creator Spada, Francesca

Search Results

31. Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel. Issue 6 (14th June 2022)

32. Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors. (2nd December 2019)

33. Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors. (25th May 2017)

34. Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors. (12th August 2014)

35. Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors. (15th April 2015)

36. Real‐World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors. (12th August 2014)

37. Real‐World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors. (15th April 2015)

40. Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis. (November 2019)